Approximately 1.1 million Americans have an acute myocardialinfarction each year. The size of the infarction is a majordeterminant of both the risk of death and the likelihood ofsubsequent heart failure. For this reason, a goal of therapyis to reduce the size of the infarct. Current treatments focuson restoration of coronary blood flow (through reperfusion)and reduction of myocardial oxygen demand (e.g., through theuse of beta-blockers). Research during the past two decades,however, has tried to elucidate the critical steps in the injuryand subsequent killing of myocardial cells, with the hope thatantagonizing these . . . [Full Text of this Article]
Source Information
From the Departments of Medicine and Cell Biology, Cardiovascular Research Center and Cancer Center, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, N.Y. (R.N.K.); and the Departments of Pathology and Medicine, University of California, Davis, Davis (I.J.).
This article has been cited by other articles:
Salio, M., Chimenti, S., De Angelis, N., Molla, F., Maina, V., Nebuloni, M., Pasqualini, F., Latini, R., Garlanda, C., Mantovani, A.
(2008). Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction. Circulation
117: 1055-1064
[Abstract][Full Text]
Durst, R., Danenberg, H., Gallily, R., Mechoulam, R., Meir, K., Grad, E., Beeri, R., Pugatsch, T., Tarsish, E., Lotan, C.
(2007). Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury. Am. J. Physiol. Heart Circ. Physiol.
293: H3602-H3607
[Abstract][Full Text]
Fujii, H., Li, S.-H., Szmitko, P. E., Fedak, P. W.M., Verma, S.
(2006). C-Reactive Protein Alters Antioxidant Defenses and Promotes Apoptosis in Endothelial Progenitor Cells. Arterioscler. Thromb. Vasc. Bio.
26: 2476-2482
[Abstract][Full Text]